Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Registration Statement · S-1

Medline Inc.

MDLNNASDAQEQUITYCurrent

Registration Statement

Filed Oct 28, 2025Accepted Oct 28, 2025, 1:05 PM EDTCIK 2046386Accession 0001193125-25-253020
Share

Company context

We are the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. We deliver mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. Through our two segments, Medline Brand and Supply Chain Solutions, we offer approximately 335,000 med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. We hold the leading position across several of our end markets and many of our key product families. We distribute these products through our expansive network of 70 global distribution facilities, spanning over 29 million square feet of warehouse space, and our owned fleet of over 2,100 MedTrans trucks, enabling us to provide next-day delivery to 95% of our U.S. customers. Our integrated business model and customer-centric culture drives lower costs and better value for our stakeholders. This is the foundation for our durable recurring revenue base, with our net sales having grown every year since inception of the Company at a compound annual growth rate (“CAGR”) of 18%.

Current securities

Recent company filings

  1. 4 filingAug 17, 2026
  2. SCHEDULE 13G/A filingAug 11, 2026
  3. 4 filingAug 11, 2026
  4. 4 filingAug 7, 2026
  5. SCHEDULE 13G/A filingAug 7, 2026

As-filed source

Primary evidence